SG/CALL/CVS HEALTH/95/0.1/20.09.24 Share Price

Warrant

DE000SU6C2V8

Market Closed - Boerse Frankfurt Warrants 01:05:49 01/06/2024 am IST
0.022 EUR +37.50% Intraday chart for SG/CALL/CVS HEALTH/95/0.1/20.09.24
1 month-44.44%
3 months-69.70%
Date Price Change
31/24/31 0.02 +25.00%
30/24/30 0.016 +60.00%
29/24/29 0.01 -16.67%
28/24/28 0.012 -20.00%
27/24/27 0.015 +15.38%

Real-time Boerse Frankfurt Warrants

Last update May 01, 2024 at 01:05 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SU6C2V
ISINDE000SU6C2V8
Date issued 28/12/2023
Strike 95 $
Maturity 20/09/2024 (111 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.25
Lowest since issue 0.009
Spread 0.01
Spread %30.30%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
59.6 USD
Average target price
70.17 USD
Spread / Average Target
+17.73%
Consensus